Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Liver Metastases Treatment Market, by Region, 2019-2029 (USD Billion)
1.2.2. Liver Metastases Treatment Market, by Type, 2019-2029 (USD Billion)
1.2.3. Liver Metastases Treatment Market, by Primary Cancer, 2019-2029 (USD Billion)
1.2.4. Liver Metastases Treatment Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Liver Metastases Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Liver Metastases Treatment Market Dynamics
3.1. Liver Metastases Treatment Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing cases of breast and colorectal cancer
3.1.1.2. Increasing government support and initiatives in cancer treatment
3.1.2. Market Challenges
3.1.2.1. High Cost of Liver Metastases Treatment
3.1.3. Market Opportunities
3.1.3.1. Technological advancements in Liver Metastases Treatment
3.1.3.2. Increasing R&D in healthcare
Chapter 4. Global Liver Metastases Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Liver Metastases Treatment Market, by Type
6.1. Market Snapshot
6.2. Global Liver Metastases Treatment Market by Type, Performance – Potential Analysis
6.3. Global Liver Metastases Treatment Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Liver Metastases Treatment Market, Sub Segment Analysis
6.4.1. Chemotherapy
6.4.2. Targeted Therapy
6.4.3. Immunotherapy
Chapter 7. Global Liver Metastases Treatment Market, by Primary Cancer
7.1. Market Snapshot
7.2. Global Liver Metastases Treatment Market by Primary Cancer, Performance – Potential Analysis
7.3. Global Liver Metastases Treatment Market Estimates & Forecasts by Primary Cancer 2019-2029 (USD Billion)
7.4. Liver Metastases Treatment Market, Sub Segment Analysis
7.4.1. Colorectal Cancer
7.4.2. Breast Cancer
Chapter 8. Global Liver Metastases Treatment Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Liver Metastases Treatment Market by Distribution Channel, Performance – Potential Analysis
8.3. Global Liver Metastases Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Liver Metastases Treatment Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Specialty Pharmacies
Chapter 9. Global Liver Metastases Treatment Market, Regional Analysis
9.1. Liver Metastases Treatment Market, Regional Market Snapshot
9.2. North America Liver Metastases Treatment Market
9.2.1. U.S. Liver Metastases Treatment Market
9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Primary Cancer breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Liver Metastases Treatment Market
9.3. Europe Liver Metastases Treatment Market Snapshot
9.3.1. U.K. Liver Metastases Treatment Market
9.3.2. Germany Liver Metastases Treatment Market
9.3.3. France Liver Metastases Treatment Market
9.3.4. Spain Liver Metastases Treatment Market
9.3.5. Italy Liver Metastases Treatment Market
9.3.6. Rest of Europe Liver Metastases Treatment Market
9.4. Asia-Pacific Liver Metastases Treatment Market Snapshot
9.4.1. China Liver Metastases Treatment Market
9.4.2. India Liver Metastases Treatment Market
9.4.3. Japan Liver Metastases Treatment Market
9.4.4. Australia Liver Metastases Treatment Market
9.4.5. South Korea Liver Metastases Treatment Market
9.4.6. Rest of Asia Pacific Liver Metastases Treatment Market
9.5. Latin America Liver Metastases Treatment Market Snapshot
9.5.1. Brazil Liver Metastases Treatment Market
9.5.2. Mexico Liver Metastases Treatment Market
9.6. Rest of The World Liver Metastases Treatment Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. F. Hoffmann – La Roche Ltd.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. AstraZeneca
10.2.3. Bayer AG
10.2.4. Eli Lilly and Company
10.2.5. Ono Pharmaceutical
10.2.6. Pfizer, Inc.
10.2.7. Bristol – Myers Squibb Company
10.2.8. Cadila Pharmaceuticals Ltd.
10.2.9. Biocare Medical, LLC
10.2.10. Foundation Medicine, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
